Comment by
Wino115 on Jan 10, 2023 4:03pm
Now that would be a nice sales partner. Get that combo drug plan going THTX.
Comment by
scarlet1967 on Jan 10, 2023 4:25pm
We could say the same for their NASH asset, despite the promising results from mono therapies recently a combo therapy would be needed to tackle a condition like NASH heterogeneous, growing prevalence and estimated market at $35 billion....
Comment by
Trogarzon on Jan 10, 2023 4:33pm
The market panicked beyond stupid in december. The analysts did'nt budge on the pause news. We're oversold by a mile. The only crooks here are the negative posts and the ambulance chasers that work hand in hand with the shorts.
Comment by
Trogarzon on Jan 10, 2023 8:47pm
I don't think you call me stupid if I was in front of you.